Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material)

Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material)

The designation “Psychedelics” has meant different things since first coined in 1957. In this 1.5 hour recording, we discuss how psychedelic compounds may provide therapeutic benefit in the treatment of serious mental illnesses and substance or alcohol use disorders. We also discuss the difficulties in conducting unbiased clinical trials to demonstrate therapeutic efficacy.

  • Provider:American Academy of Addiction Psychiatry
  • Activity Link: https://www.aaap.org/education/upcoming-and-on-demand-webinars/
  • Start Date: 2023-06-01 05:00:00
  • End Date: 2023-06-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.